CKF-23607-89869
3 vaccinations
7 coded responses
27 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 983 / WA
- Registered
- 2020-12-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-24
Registered in v-safe
-
2020-12-24
Dose 1 — Moderna
- 2020-12-24
-
2020-12-25
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease — Feeling: Good · Site: PainFree text: I have myasthenia gravis, asthma, acne, and eczema comorbidities.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-26
-
2020-12-27
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea — Feeling: Fair · Fatigue or tirednessFree text: Shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-28
- 2020-12-29
-
2020-12-30
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease — Feeling: Fair · Headache, Fatigue or tirednessFree text: I have myasthenia gravis as a comorbidity.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-31
-
2021-01-07
Survey response — day 14, dose 1MedDRA: Headache, Paranasal sinus inflammation — Feeling: GoodFree text: I had headaches for about 5 days, which I believe are due to breathing in smoke and sinus inflammation.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-14
- 2021-01-21
-
2021-01-23
Dose 2 — Moderna
- 2021-01-23
-
2021-01-24
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, Abdominal painAdult check-in
-
2021-01-27
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue, Pre-existing disease — Feeling: Fair · Fatigue or tirednessFree text: I have myasthenia gravis and often have fatigue.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Abdominal painAdult check-in
- 2021-01-30
- 2021-02-15
- 2021-02-20
- 2021-03-01
- 2021-03-06
- 2021-04-26
-
2021-07-24
Survey response — 6 months, dose 2MedDRA: Myasthenia gravis, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Worsening of my myasthenia gravis symptoms, which I attribute to a medication change.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-24
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-10
-
2021-08-15
Dose 3 — Moderna
- 2021-11-16
- 2022-02-15
-
2022-08-15
Survey response — 12 months, dose 3MedDRA: COVID-19, Cough, Fatigue, Headache, Taste disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I had covid and had the typical headache, cough, fatigue. I also had a change in taste, but believe this was due to the paxlovid, not the covid infection itself.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-15
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-08-16
Call successfulParticipant prefers to complete VAERS report online
-
2022-08-16
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-24 | Moderna | |
| 2 | 2021-01-23 | Moderna | |
| 3 | 2021-08-15 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): I have myasthenia gravis, asthma, acne, and eczema comorbidities.
Systemic reaction (other): Shortness of breath
Systemic reaction (other): I have myasthenia gravis as a comorbidity.
Release 1 — day 14, dose 1
Symptoms: I had headaches for about 5 days, which I believe are due to breathing in smoke and sinus inflammation.
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): I have myasthenia gravis and often have fatigue.
Release 9 — 6 months, dose 2
Symptoms: Worsening of my myasthenia gravis symptoms, which I attribute to a medication change.
Release 12 — 12 months, dose 3
Symptoms: I had covid and had the typical headache, cough, fatigue. I also had a change in taste, but believe this was due to the paxlovid, not the covid infection itself.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Myasthenia gravis | ✓ | · | ✓ |
| SD | Paranasal sinus inflammation | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Taste disorder | · | · | ✓ |
| SD | Therapy change | ○ | · | ○ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release